Prosecution Insights
Last updated: October 04, 2026
Application No. 18/746,502

Endotracheal tube position anomaly alerting device

Non-Final OA §101§102§103§112
Filed
Jun 18, 2024
Priority
May 09, 2024 — TW 113117248
Examiner
WOLFF, ARIELLE R
Art Unit
Tech Center
Assignee
Kaohsiung Medical University
OA Round
1 (Non-Final)
47%
Grant Probability
Moderate
1-2
OA Rounds
1y 3m
Est. Remaining
82%
With Interview

Examiner Intelligence

Grants 47% of resolved cases
47%
Career Allowance Rate
88 granted / 187 resolved
-12.9% vs TC avg
Strong +35% interview lift
Without
With
+34.7%
Interview Lift
resolved cases with interview
Typical timeline
3y 6m
Avg Prosecution
31 currently pending
Career history
229
Total Applications
across all art units

Statute-Specific Performance

§101
3.8%
-36.2% vs TC avg
§103
58.3%
+18.3% vs TC avg
§102
12.8%
-27.2% vs TC avg
§112
21.8%
-18.2% vs TC avg
Black line = Tech Center average estimate • Based on career data from 187 resolved cases

Office Action

§101 §102 §103 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . This action is in response to the filing on 6/18/2024. Since the initial filing, no claims have been added, amended or cancelled. Thus, claims 1-9 are pending in the application. Claim Rejections - 35 USC § 101 35 U.S.C. 101 reads as follows: Whoever invents or discovers any new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof, may obtain a patent therefor, subject to the conditions and requirements of this title. Claim 9 is rejected under 35 U.S.C. 101 because Section 33(a) of the America Invents Act reads as follows: Notwithstanding any other provision of law, no patent may issue on a claim directed to or encompassing a human organism. Claim 9 is rejected under 35 U.S.C. 101 and section 33(a) of the America Invents Act as being directed to or encompassing a human organism. See also Animals - Patentability, 1077 Off. Gaz. Pat. Office 24 (April 21, 1987) (indicating that human organisms are excluded from the scope of patentable subject matter under 35 U.S.C. 101). Claim 9 positively recites the patient in a manner which encompasses the patient. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 1-9 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claim 1 recites the limitation of identifying “presence of a tracheal carina, an endotracheal tube (ETT) and a tracheostomy tube” in line 6-7. It is unclear if the endotracheal tube (ETT) and the tracheostomy tube are intended to be alternatives. Based upon the further language of claim 1, language found in dependent claims, and the disclosure of the instant specification, Examiner is interpreting the endotracheal tube (ETT) and the tracheostomy tube as alternatives. Should this be the correct interpretation, Examiner suggests amending to “presence of a tracheal carina and an endotracheal tube (ETT) or a tracheostomy tube” to clarify. Dependent claims inherit the rejection of their predecessors. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(2) the claimed invention was described in a patent issued under section 151, or in an application for patent published or deemed published under section 122(b), in which the patent or application, as the case may be, names another inventor and was effectively filed before the effective filing date of the claimed invention. Claim(s) 1 and 4-9 is/are rejected under 35 U.S.C. 102(a)(2) as being anticipated by Tegzes (US 2024/0164845). In regards to claim 1, Tegzes discloses as endotracheal tube position anomaly alerting device, for monitoring correctness of a position of an endotracheal tube (analysis apparatus 200), comprising: a monitoring module for collecting patients’ chest X-ray image data (imaging device may be x-ray, paragraph 56 and 72, data source 210, paragraph 93); an object detection module connected to the monitoring module to receive the chest X-ray image data from the monitoring module and use an artificial intelligence (AI) algorithm model (AI system 220, paragraph 93) to identify presence of a tracheal carina, an endotracheal tube (ETT) and a tracheostomy tube and mark positions thereof in the chest X-ray image data (paragraph 94 and 106); a position evaluation module connected to the object detection module to automatically measure a distance between an endotracheal tube tip and the tracheal carina upon detection of presence of the tracheal carina and the endotracheal tube by the object detection module and according to mark positions of a determination result of the artificial intelligence (AI) algorithm model (distance computer 1030, paragraph 102-103), generate an evaluation result of the endotracheal tube position appropriateness according to the distance thus measured (paragraph 122 and 125), and trigger an alert when the evaluation result indicates that the position of the endotracheal tube does not fall within a correct range (paragraph 126, Fig 5); and a display module connected to the position evaluation module to receive the determination result of the object detection module and the position evaluation module, send an alerting signal, and display an object marking result and the evaluation result of the endotracheal tube position appropriateness (paragraph 125-126, Fig 5). In regards to claim 4, Tegzes discloses the device of claim 1 and Tegzes further discloses wherein the position evaluation module measures the distance between the endotracheal tube tip and the tracheal carina by selecting the leftmost coordinate pair and the rightmost coordinate pair on the lower edge of a marking bounding box of the identified endotracheal tube tip and the midpoint between two points calculated with a function, calculating a distance from each of the three points to the tracheal carina with Euclidean distance equation, selecting the shortest distance, and converting pixel values of the distance in the image into the actual distance (paragraph 103 and 123 and 127). In regards to claim 5, Tegzes discloses the device of claim 1 and Tegzes further discloses wherein the position evaluation module triggers an alert (paragraph 126) when the endotracheal tube tip is lower than the tracheal carina or when the distance between the endotracheal tube tip and the tracheal carina is less than 3 cm or greater than 5 cm (paragraph 125, Fig 5). In regards to claim 6, Tegzes discloses the device of claim 1 and Tegzes further discloses wherein a means of triggering the alert includes but is not limited to a picture, a flashing picture or sound (paragraph 75 line 12-19 and paragraph 125). In regards to claim 7, Tegzes discloses the device of claim 5 and Tegzes further discloses wherein a means of triggering the alert includes but is not limited to a picture, a flashing picture or sound (paragraph 75 line 12-19 and paragraph 125). In regards to claim 8, Tegzes discloses the device of claim 1 and Tegzes further discloses wherein the chest X-ray image data of the object detection module includes chest X-ray images indicative of the presence of the endotracheal tube, chest X-ray images indicative of the presence of the tracheostomy tube, and chest X-ray images indicative of the absence of the endotracheal tube or tracheostomy tube (paragraph 73-74 and 108). In regards to claim 9, Tegzes discloses the device of claim 1 and Tegzes further discloses wherein the chest X-ray images indicative of the presence of the endotracheal tube mainly originate from the chest X-rays of patients who need to undergo endotracheal tube-based therapy, including cases where the endotracheal tube positions are appropriate and cases where the endotracheal tube positions are inappropriate, with the patients differing in endotracheal tube experience and thoracic anatomical structures (paragraph 73-74 and 108 and 126). Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claim(s) 2-3 is/are rejected under 35 U.S.C. 103 as being unpatentable over Tegzes (US 2024/0164845) in view of Gustin (US 2022/0398814) and Kim (US 2023/0088974). In regards to claim 2, Tegzes discloses the device of claim 1 and Tegzes further discloses wherein the object detection module, inputs a plurality of chest X-ray image data, treats the plurality of chest X-ray image data as a training dataset (paragraph 74 line 43-49) and a testing dataset for deep learning according to a predetermined ratio (paragraph 84), performs model training with the training dataset, performs testing with the testing dataset (paragraph 84). Tegzes does not wherein the deep learning model is YOLOv5, performs verification to finish training the artificial intelligence (AI) algorithm model, and evaluates the performance of the artificial intelligence (AI) algorithm model according to a standard performance evaluation indicator. However, Gustin teaches a medical imaging system using a deep learning model wherein the deep learning model is YOLOv5 (paragraph 76). Further, Kim teaches wherein the system performs verification to finish training the artificial intelligence (AI) algorithm model (paragraph 146), and evaluates the performance of the artificial intelligence (AI) algorithm model according to a standard performance evaluation indicator (paragraph 149-150). Therefore, it would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to modify Tegzes wherein the deep learning model is YOLOv5, performs verification to finish training the artificial intelligence (AI) algorithm model, and evaluates the performance of the artificial intelligence (AI) algorithm model according to a standard performance evaluation indicator as taught by Gustin and Kim as these are known models and methods for testing such models. In regards to claim 3, Tegzes in view of Gustin and Kim teaches the device of claim 2 and the combination further teaches wherein the standard performance evaluation indicator includes but is not limited to precision, recall, mean average precision (mAP@50), and accuracy (Kim: paragraph 149). Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to Arielle Wolff whose telephone number is (571)272-8727. The examiner can normally be reached Mon-Fri 8:00-4:00. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Kendra Carter can be reached at (571) 272-9034. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /ARIELLE WOLFF/ Examiner, Art Unit 3785 /PAIGE KATHLEEN BUGG/ Primary Examiner, Art Unit 3785
Read full office action

Prosecution Timeline

Jun 18, 2024
Application Filed
Sep 22, 2026
Non-Final Rejection mailed — §101, §102, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12721775
HIGH FREQUENCY CHEST WALL OSCILLATION PUMP
2y 2m to grant Granted Sep 01, 2026
Patent 12678368
Systems and Methods for Providing Resuscitation Guidance based on Physical Features of a Patient Measured During an Acute Care Event
7y 0m to grant Granted Jul 14, 2026
Patent 12661470
NASAL MASK INTERFACE ASSEMBLY
2y 9m to grant Granted Jun 23, 2026
Patent 12636448
VENTILATION DEVICE AND METHOD
4y 12m to grant Granted May 26, 2026
Patent 12636221
EXOSKELETON ROBOT FOR EXPECTORATION ASSISTANCE AND CONTROL METHOD
3y 8m to grant Granted May 26, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
47%
Grant Probability
82%
With Interview (+34.7%)
3y 6m (~1y 3m remaining)
Median Time to Grant
Low
PTA Risk
Based on 187 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month